Delivery Order SPE2DB24D2101-SPE2DB25FKPBA
- Not listed
- The Defense Logistics Agency awarded a $3,663.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for cefpodoxime 200 mg tablets (20-count) with a completion date of September 2, 2025. This contract is classified as a non-set-aside award, meaning it was competitively awarded without restrictions on eligible bidders. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.48 to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, firm fixed-price contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 for a ceiling value of $1,949.17. This contract represents a non-set-aside, competitively awarded delivery order utilizing firm fixed pricing and is scheduled for completion by August 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,705.38 firm fixed-price contract is for the delivery of 4,567,914,247 units of the antibiotic cefpodoxime 200 mg tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,891.20 Firm Fixed Price delivery order is for the supply of 4,565,927,875 Cefpodoxime 100 mg tablets in 20-count packages. The award has a completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Cefpodoxime 200 mg tablets, a prescription medication, with a ceiling value of $1,328.26 and a period of performance through August 8, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cefpodoxime 200 mg tablets. The contract has a ceiling value of $13,005.55 and a completion date of August 6, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen has significant indefinite delivery contracts (IDCs) with the DLA and Department of Justice Federal Bureau...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.70 firm fixed-price delivery order is for the supply of 4566947370 CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,300,894 units of the prescription drug Cefpodoxime 100 mg tablets. The $5,808.14 firm fixed-price contract has a completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency awarded a $1,638.24 delivery order to AmerisourceBergen Drug Corp for Cefpodixome 200 mg tablets (20-count units) under a firm fixed-price contract, with an ultimate completion date of August 11, 2025. This award utilizes no set-aside designation and represents a competitive procurement for pharmaceutical supplies. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters. This delivery order...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPBADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,672.34 to AmerisourceBergen Drug Corp for Cefpodoxime 200 mg tablets in quantities of 20 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As a non-set-aside award, this delivery order reflects AmerisourceBergen's capability to meet federal procurement requirements through open competition and represents one of numerous deliveries under this prime vendor contract serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.7k | 8/28/25 |